ANVISA grants DuPont health claim for probiotic
The Brazilian Health Regulatory Agency (ANVISA) has approved a health claim for DuPont Nutrition & Health’s Bifidobacterium lactis HN019 probiotic strain for gastrointestinal health.
Archives for May 24, 2018
Doctor’s Best betting that clear fish oil will help its omega-3s line shine
Supplement brand holder Doctor’s Best is betting that clarity can be a differentiator in the fish oil space as it debuts a new line of omega-3 softgels.
FDA warns three more kratom marketers over opioid treatment, other disease claims
Kratom is again in the crosshairs as federal authorities sent out three more warning letters to companies making illegal opioid addiction treatment claims for the botanical.
Omega-3, omega-6 may improve obesity-related glucose issues… in rats at least
A new study on rats suggests that ALA and LA dietary supplementation may offer several benefits to obese individuals by altering gene expression.
When transparency is no longer a differentiator, supplement brands need to be creative with corporate social responsibility
As more supplement brands go great lengths to be transparent to consumers, communicating corporate social responsibility (CSR) creatively becomes key.
ALANUR fights for dietary supplement regulation in Latin America with focus on understanding consumer habits
The Latin American Responsible Nutrition Alliance (ALANUR) is working alongside other organizations to harmonize regulations for dietary supplements and understand consumer habits in the expansive and dynamic region of Latin America, home to roughly 625...
Omega-3s from plants: ‘This technology is going to have a massive impact on the industry’
As demand for omega-3s continues to rise, alternative sources are being explored, with many think that genetically engineered oil seed crops could have a massive impact on easing pressure on fish stocks.
Lack of understanding of fatty liver disease in Taiwan reveals opportunity for supplement and functional food firms
Supplement and functional food firms have a considerable opportunity to help educate consumers, and increase sales, of products targeted to improve fatty liver disease.